HilleVax, Inc.
General ticker "HLVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $93.9M (TTM average)
HilleVax, Inc. follows the US Stock Market performance with the rate: 55.5%.
Estimated limits based on current volatility of 0.3%: low 2.09$, high 2.10$
Factors to consider:
- Total employees count: 84 (-6.7%) as of 2024
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.36$, 4.64$]
- 2025-12-31 to 2026-12-31 estimated range: [1.29$, 3.94$]
Financial Metrics affecting the HLVX estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Shareholder equity ratio, % of 80.17 > 62.64
- Negative: Operating cash flow per share per price, % of -116.29 <= 0.99
- Positive: Investing cash flow per share per price, % of 62.42 > -0.78
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
Short-term HLVX quotes
Long-term HLVX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $65.11MM | $133.34MM | $155.29MM |
| Operating Income | $-65.11MM | $-133.34MM | $-155.29MM |
| Non-Operating Income | $-94.70MM | $9.78MM | $8.02MM |
| Interest Expense | $3.41MM | $2.39MM | $3.32MM |
| R&D Expense | $45.91MM | $106.68MM | $78.17MM |
| Income(Loss) | $-159.81MM | $-123.57MM | $-147.27MM |
| Profit(Loss)* | $-257.00MM | $-123.57MM | $-147.27MM |
| Stockholders Equity | $267.23MM | $265.52MM | $154.49MM |
| Assets | $317.21MM | $344.43MM | $192.69MM |
| Operating Cash Flow | $-61.99MM | $-86.78MM | $-108.79MM |
| Capital expenditure | $6.51MM | $10.75MM | $0.52MM |
| Investing Cash Flow | $-6.51MM | $-94.64MM | $58.40MM |
| Financing Cash Flow | $224.97MM | $118.70MM | $-11.82MM |
| Earnings Per Share** | $-6.83 | $-3.04 | $-3.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.